Signova Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 4.00 M
as on 16-12-2024
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 41.29 Cr
as on 16-12-2024
- Satisfied Charges ₹ 14.95 Cr
as on 16-12-2024
- Revenue 28.26%
(FY 2022)
- Profit 89.01%
(FY 2022)
- Ebitda 73.04%
(FY 2022)
- Net Worth 43.25%
(FY 2022)
- Total Assets 48.28%
(FY 2022)
About Signova Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹41.29 Cr. The company has closed loans amounting to ₹14.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Satrajit Kanungo and Ranjan Deka serve as directors at the Company.
- CIN/LLPIN
U51397AS2008PTC008558
- Company No.
008558
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Signova Pharma Private Limited offer?
Signova Pharma Private Limited offers a wide range of products and services, including Vitamins & Supplements, Mineral Supplements, Skin Care, Facewash, Personal Care, Oral Care.
Who are the key members and board of directors at Signova Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satrajit Kanungo  | Director | 04-Jan-2008 | Current |
| Ranjan Deka | Director | 04-Jan-2008 | Current |
Financial Performance and Corporate Structure Insights of Signova Pharma.
Signova Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.26% increase. The company also saw a substantial improvement in profitability, with a 89.01% increase in profit. The company's net worth Soared by an impressive increase of 43.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Signova Pharma?
In 2022, Signova Pharma had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Signova Healthcare Private LimitedActive 27 years 8 monthsSatrajit Kanungo and Ranjan Deka are mutual person
Signova Healthcare Unit Iii Private LimitedActive 2 months 8 daysSatrajit Kanungo and Ranjan Deka are mutual person
- North East Medical Care And Research Centre Pvt LtdActive 29 years 30 days
Ranjan Deka is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Mar 2024 | ₹2.00 M | Open |
Others Creation Date: 15 Feb 2024 | ₹1.61 M | Open |
Others Creation Date: 15 Feb 2024 | ₹1.70 M | Open |
How Many Employees Work at Signova Pharma?
Signova Pharma has a workforce of 421 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Signova Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Signova Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
